Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02864641 · ClinicalTrials.gov registry record · Phase 2
Mobile Technology and Online Tools to Track Adherence in Chronic Illness Patients
A Phase 2 study, sponsored by 3-C Institute for Social Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
NCT02864641: Completed Phase 2 study, sponsored by 3-C Institute for Social Development.
NCT02864641 is a Phase 2 study that has completed, run by 3-C Institute for Social Development. The registered enrollment target is 68 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02864641, a Phase 2 study, has completed, sponsored by 3-C Institute for Social Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this project is to test the efficacy of Planet K, a mobile and web-based technology infrastructure specifically designed to (a) enhance youths' chronic kidney disease- and treatment-related knowledge through interactive and game-based educational materials; (b) support adherence to the treatment regimen through customized task prompts via mobile and web-based delivery; and (c) promote patient-provider communication through real-world data collection and feedback loops. Investigators will examine the effectiveness of the Planet K mobile app and website in improving treatment adherence, disease-related knowledge, transition readiness, condition management, and the psychological correlates of these variables in adolescents and young adults with chronic kidney disease (CKD).
Primary Outcome
Both parents and adolescent participants will complete a consultant-created 25 item questionnaire to assess their knowledge of CKD.
Interventions
- BEHAVIORAL Planet K
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-06 |
| Phase | Phase 2 |
What the finished NCT02864641 record still lists
NCT02864641 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (49% lower).
The record links to 0 conditions, and to 1 intervention - of which Planet K is the first listed.
NCT02864641 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02864641 about?
NCT02864641 is a clinical study titled "Mobile Technology and Online Tools to Track Adherence in Chronic Illness Patients". The purpose of this project is to test the efficacy of Planet K, a mobile and web-based technology infrastructure specifically designed to (a) enhance youths' chronic kidney disease- and treatment-related knowledge through interactive and game-based educational materials; (b) support adherence to th...
What is the current status of trial NCT02864641?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 2015-07. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02864641?
The interventions under investigation include: Planet K (BEHAVIORAL).
Who is sponsoring clinical trial NCT02864641?
This trial is sponsored by 3-C Institute for Social Development, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02864641's enrollment target sits among peer trials
68 967th of 2000 higher than 1,027 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia